ASX Stocks In Focus: 5 Shares Built for Resilience Amid Volatility in 2026
Five ways to position for sticky inflation, energy shocks and AI demand.
Most Popular
Grow your wealth. Expand your knowledge. Leverage strategic insight.
The Investor Standard delivers world-class market analysis, stock recommendations, and exclusive insights to help you make smarter investment decisions and stay ahead of the market.
ASX Sector Rotation: Why Investors Are Moving Beyond Tech Hype and Back Into Real Assets
The ASX Sector Rotation 2026 story is not really about a collapse in tech. It is about investors changing what…
ASX IPO Market 2026: Why Small-Cap Listings Are Back on the Radar
The ASX IPO window is reopening, but investors are backing quality over hype.
ASX REIT Sector Outlook
The A-REIT sector went through a difficult 2025, with the S&P/ASX 200 A-REIT Index falling while the broader market moved…
ASX Weekly Market Wrap
Markets Are Rolling Over, But the Rotation Matters More Australian equities have now extended their losing streak to four straight…
Markets
Harvey: The Legal Ai Company Receives Funding at a US $11 Billion Valuation
Business Summary Harvey is a growing legal AI company founded in 2022 by former lawyer Winston Weinberg and AI researcher Gabe Pereyra, focused on bringing…
Highlighted Insights
ASX Mining Stocks: Fuel Constraints, Falling Commodities and What Comes Next
The sell-off reveals a deeper issue in Australia's mining system.
Australia’s ETF Boom Has Created a New Problem
Australia’s ETF market has expanded rapidly. There are more than 450 products now listed across the ASX and Cboe Australia,…
5 ASX Stocks To Own in a Higher Rate, Higher Volatility Market
The Australian market is dealing with two forces at once. The first is a renewed inflation shock from energy, driven…
Rate Hike Bets Surge as Bond Markets Price Inflation Shock – But Are They Overdoing It?
Markets are pricing more rate hikes, but the economy may not handle them.
Gold Price Outlook: Why Gold Is Falling During War as Oil and Rates Take Control
Gold is falling during crisis, and the reason lies in oil and interest rates.
Featured Investments (Stock Picks)
Bellevue Gold Investment Analysis (ASX: BGL): High-Grade Asset, High-Pressure Delivery
High-Grade Gold with Little Room for Error This Bellevue Gold investment analysis examines a company…
Artrya (ASX: AYA) Investment Analysis: Can This AI-Driven Medtech Find Its Commercial Breakthrough?
Artrya has built its story around a simple but powerful problem. Heart disease remains the…
Unlock Smarter Investing
Gain access to independent ASX insights, exclusive stock picks, and in-depth research trusted by founders, boards, and investors.
ASX: A2Milk Market Update
A2Milk has been on the front page of various financial news pages over the past…
Pointerra Ltd (ASX: 3DP): Speculative Investment Analysis
Company Overview Pointerra Ltd (ASX: 3DP) is an Australian geospatial technology company that helps industries…
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Explore More Insights
DroneShields Revenue Surges, but Pipeline Concerns Test Investor Confidence
DroneShield has delivered what, on the surface, looks like a blockbuster result. Revenue at the defence technology company nearly quadrupled…
Argent Minerals Limited (ASX: ARD): Speculative Stock Analysis
Business Snapshot Argent Minerals is an Australian exploration company chasing polymetallic resources across NSW and WA. Its flagship Kempfield Project…
Lynas Rare Earths (ASX: LYC): Equity Analysis
Lynas Rare Earths is the largest producer of rare earth elements outside China, with operations spanning the Mt Weld mine…
An Outlook on Private Credit
Private credit, which involves lending by non-bank institutions, has grown rapidly in recent years as borrowers seek flexible financing solutions.…
Cynata Therapeutics (ASX: CYP): Speculative Investment Analysis
Business Overview Cynata Therapeutics is a clinical-stage biotechnology company developing cell therapies based on Cymerus, its induced pluripotent stem cell…
ASX Outlook: Is Hub24 an Overvalued Stock?
Business Summary HUB24 Limited is an Australian provider of integrated platform, technology, and data services to the financial services industry.…
Socials
Monthly Investor Memo
Delivered Monthly - 2026